sb 203580 has been researched along with Cardiomyopathy, Congestive in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Ameen, M; Arthur Ataam, J; Bharucha, N; Bruyneel, AAN; Diecke, S; Feyen, DAM; Furihata, T; Gavidia, AA; Karakikes, I; Kaur, B; Lim, EW; Martinez-Amador, N; Mercola, M; Metallo, CM; Monte, E; Nair, P; Perea-Gil, I; Seeger, T; Serrano, R; Snyder, MP; Termglinchan, V; Vadgama, N | 1 |
Cao, J; Du, Y; Han, X; Li, X; Liu, H; Song, K; Wang, J; Yan, L; Zhan, W | 1 |
Akita, Y; Enoki, C; Fujiwara, H; Imamura, H; Iwasaka, T; Kamihata, H; Kyoi, S; Matsuhisa, S; Otani, H; Tatsumi, K | 1 |
3 other study(ies) available for sb 203580 and Cardiomyopathy, Congestive
Article | Year |
---|---|
Serine biosynthesis as a novel therapeutic target for dilated cardiomyopathy.
Topics: Activating Transcription Factor 4; Adenosine Triphosphate; Anti-Inflammatory Agents, Non-Steroidal; Carbazoles; Cardiomyopathy, Dilated; Drug Evaluation, Preclinical; Glucose; Glycine; Humans; Imidazoles; Induced Pluripotent Stem Cells; Molecular Targeted Therapy; Mutation; Myocytes, Cardiac; Phosphoglycerate Dehydrogenase; Protein Kinase Inhibitors; Pyridines; Serine; Troponin T | 2022 |
β1-Adrenoceptor autoantibodies from DCM patients enhance the proliferation of T lymphocytes through the β1-AR/cAMP/PKA and p38 MAPK pathways.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Agonists; Aged; Animals; Autoantibodies; Cardiomyopathy, Dilated; Cell Proliferation; Cyclic AMP-Dependent Protein Kinases; Female; Humans; Imidazoles; Interferon-gamma; Isoproterenol; Isoquinolines; Male; Metoprolol; Middle Aged; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Protein Kinase Inhibitors; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Signal Transduction; Sulfonamides; T-Lymphocytes | 2012 |
Opposing effect of p38 MAP kinase and JNK inhibitors on the development of heart failure in the cardiomyopathic hamster.
Topics: Animals; Anthracenes; Apoptosis; Cardiomyopathy, Dilated; Cricetinae; Fibrosis; Imidazoles; Immunoblotting; In Situ Nick-End Labeling; JNK Mitogen-Activated Protein Kinases; Male; Microscopy, Fluorescence; Myocardium; p38 Mitogen-Activated Protein Kinases; Pyrazoles; Pyridines; Ventricular Dysfunction, Left | 2006 |